Research and Markets (http://www.researchandmarkets.com/research/382nnk/global) has announced the addition of the "Global Post-traumatic Stress Disorder Therapeutics Market 2015-2019" report to their offering.
The report identifies strategic alliances as one of the key trends in the Global Post-traumatic Stress Disorder Therapeutics Market. This takes place in form of licensing and collaboration, where companies will help each other in the development and commercialization of drugs in different regions.
The report predicts further growth in this market, at a CAGR of 1.09%, over the forecasted period. This is based on the increasing number of cases of accidents and violence around the world. Stress levels in individuals are rising worldwide because of:
-
The rise in conflicts between different countries
-
Domestic and social violence.
The report finds that those in the military are particularly affected. And, the report states that the unavailability of standard diagnostic methods to identify PTSD is hindering growth.
Key Questions Answered in this Report:
- What will the market size be in 2019 and what will the growth rate be?
- What are the key Market Trends?
- What is driving this market?
- What are the challenges to market growth?
- Who are the key vendors in this market space?
- What are the market opportunities and threats faced by the key vendors?
- What are the strengths and weaknesses of the key vendors?
Companies Mentioned:
- GlaxoSmithKline plc
- Pfizer Inc.
- Otsuka Pharmaceutical Co. Ltd.
- Abbott Laboratories
- Addex Therapeutics
- AstraZeneca
- Azevan Pharmaceuticals
- Baylor Research Institute
- Cerecor
- Chugai Pharmaceutical
- Dart NeuroScience
- Dr. Reddy's Laboratories
- Edgemont Pharmaceuticals
- Eli Lilly
- F. Hoffmann-La Roche
- Forest Laboratories
- H. Lundbeck
- Humanetics Pharmaceuticals
- Intra-Cellular Therapies
- Janssen Pharmaceuticals
- Luye Pharma
- Marinus Pharmaceuticals
- Nanotherapeutics
- Naurex
- Neurocrine Biosciences
- Novartis Pharmaceuticals
- Suven
- Synchroneuron
- Takeda Pharmaceutical
- Teva Pharmaceutical
- Tonix Pharmaceuticals
Report Structure:
01. Executive Summary
02. List of Abbreviations
03. Scope of the Report
04. Market Research Methodology
05. Product Profiles
06. Introduction
07. PTSD Overview
08. Pipeline Analysis
09. Market Landscape
10. Market Segmentation by Class of Drug
11. Geographical Segmentation
12. Buying Criteria
13. Market Growth Drivers
14. Drivers and Their Impact
15. Market Challenges
16. Impact of Drivers and Challenges
17. Market Trends
18. Trends and Their Impact
19. Vendor Landscape
20. Global PTSD Therapeutics Market: Key Takeaways
21. Key Vendor Analysis
22. Other Reports in This Series
For more information visit http://www.researchandmarkets.com/research/382nnk/global
View source version on businesswire.com: http://www.businesswire.com/news/home/20160114005694/en/